Effect of oral gabapentin versus placebo on pain relief after gynecologic surgery
Phase 2
- Conditions
- Pain at surgical site at inguinal area.Pain localized to other parts of lower abdomen
- Registration Number
- IRCT201402289014N28
- Lead Sponsor
- Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 102
Inclusion Criteria
(a) age of 18 to 65 years; (b) women with physical class ASA I-II; (c) candidate for elective gynecologic surgery.
Exclusion criteria: (a) contraindication for neuroaxial anesthesia; (b) history of hypertension or diabetes mellitus; (c) using narcotics or psychotropic.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain at the surgical site. Timepoint: at 1, 6, 12, 18, 24, and 48 hours after surgery. Method of measurement: using VAS scale.;The amount of narcotic used. Timepoint: during the first 48 hours after surgery. Method of measurement: per mg.;The duration of time to receive narcotic. Timepoint: during the first 48 hours after surgery. Method of measurement: per min.
- Secondary Outcome Measures
Name Time Method Vertigo. Timepoint: at 1, 6, 12, 18, 24, and 48 hours after surgery. Method of measurement: by question.;Nausea and vomiting. Timepoint: at 1, 6, 12, 18, 24, and 48 hours after surgery. Method of measurement: by question.;Pruritus. Timepoint: at 1, 6, 12, 18, 24, and 48 hours after surgery. Method of measurement: by question.